General Information of the Compound
| Compound ID |
CP0036551
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
9-chloranyl-5-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol;methanesulfonic acid
Show/Hide
|
||||||||||||||||||
| Synonyms |
6-chloro-1-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol
9-chloro-5-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol
Carlacor
Carlacor (TN)
Corlopam (TN)
Fenodopam mesylate
Fenoldopam
Fenoldopam (INN);Fenoldopam [INN:BAN]
Fenoldopamum
Fenoldopamum [Latin]
SK&F-82526
SKF 82526
SKF 82526-J
SKF-82526J
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C16H16ClNO3
|
||||||||||||||||||
| Molecular Weight |
305.761
|
||||||||||||||||||
| Canonical SMILES |
Oc1ccc(cc1)C1CNCCc2c(Cl)c(O)c(O)cc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C16H16ClNO3/c17-15-11-5-6-18-8-13(9-1-3-10(19)4-2-9)12(11)7-14(20)16(15)21/h1-4,7,13,18-21H,5-6,8H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
TVURRHSHRRELCG-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
87900-90-1
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound